Search references for EVOLOCUMAB. Phrases containing EVOLOCUMAB
See searches and references containing EVOLOCUMAB!EVOLOCUMAB
Pharmaceutical drug
Evolocumab, sold under the brand name Repatha, is a monoclonal antibody drug. It is an immunotherapy medication for the treatment of hyperlipidemia. Evolocumab
Evolocumab
American multinational biopharmaceutical company
osteoporosis and bone diseases ($6.6 billion in total 2025 revenues), Repatha (evolocumab) to treat hyperlipidemia ($3.0 billion in 2025 revenues), Otezla (apremilast)
Amgen
Mammalian protein found in humans
particle concentrations. The first two PCSK9 inhibitors, alirocumab and evolocumab, were approved as once every two week injections, by the U.S. Food and
PCSK9
Pharmaceutical drug
completed by Xiao et al., assessing the safety and efficacy of alirocumab and evolocumab found that alirocumab significantly reduces LDL-C in paediatric populations
Alirocumab
Monoclonal antibody against amyloid beta
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Donanemab
Antibodies from clones of the same blood cell
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Monoclonal_antibody
Drug class
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Anti-amyloid_antibodies
Autoimmune disease resulting in skeletal muscle weakness
nicotinic acid, cholestyramine, colestipol, colesevelam, alirocumab, and evolocumab, have been used in people without causing or worsening myasthenia gravis
Myasthenia_gravis
Fat reducing drug
PCSK9 inhibitors are monoclonal antibodies for refractory cases. (e.g. Evolocumab, Inclisiran) They are used in combination with statins. Probucol decreases
Lipid-lowering_agent
Pharmaceutical compound
for "Phase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFH" at ClinicalTrials.gov Clinical trial number NCT04797247 for "Study
Lerodalcibep
High levels of cholesterol in the blood
or in pregnant women. Injectable antibodies against the protein PCSK9 (evolocumab, bococizumab, alirocumab) can reduce LDL cholesterol and have been shown
High_cholesterol
Pharmaceutical biological monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Fremanezumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Bedinvetmab
Pharmaceutical compound
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Abciximab
Monoclonal antibody against amyloid beta
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Lecanemab
Antibodies from non-human species made nearly identical to human ones
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Humanized_antibody
Experimental monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Prasinezumab
phospholipase A2, and also did research on the efficacy and safety of evolocumab in patients with type 2 diabetes mellitus and hypercholesterolemia. Dr
Robert_S._Rosenson
Drugs that inhibit α-synuclein
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Anti-α-synuclein_drug
Medication
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Bevacizumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Emicizumab
Chemical compound
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Bimagrumab
bowel disease Evinacumab Evkeeza mab human angiopoietin 3 Y dyslipidemia Evolocumab Repatha mab human PCSK9 Y hypercholesterolemia Exbivirumab mab human hepatitis
List of therapeutic monoclonal antibodies
List_of_therapeutic_monoclonal_antibodies
evatanepag (USAN, INN) Evdi Evenity everolimus (USAN) Evfraxy Evex Evista Evolocumab (INN) Evoxac Evrysdi exagamglogene autotemcel (USAN, INN) exalamide (INN)
List_of_drugs:_Eu–Ez
Chemical compound
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Erenumab
Veterinary medication
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Relfovetmab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Galcanezumab
Medication
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Marstacimab
Monoclonal antibody against amyloid beta
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Aducanumab
Human monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Denosumab
Pharmaceutical drug classification
C10AX10 Alipogene tiparvovec C10AX11 Mipomersen C10AX12 Lomitapide C10AX13 Evolocumab C10AX14 Alirocumab C10AX15 Bempedoic acid C10AX16 Inclisiran C10AX17 Evinacumab
ATC_code_C10
cholesterol- and diabetes-lowering drugs, including rosuvastatin, sitagliptin, evolocumab, inclisiran, and evinacumab. Several of these treatments became standard
Robert_Hegele
Medication
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Idarucizumab
Experimental monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Cinpanemab
Veterinary medication
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Izenivetmab
Pharmaceutical drug
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Romosozumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Rinucumab
Genetic disorder characterized by high cholesterol levels
early identification of FH and treatment with statins. Alirocumab and evolocumab, both monoclonal antibodies against PCSK9, are specifically indicated
Familial_hypercholesterolemia
Medication
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Concizumab
Monoclonal antibody designed to treat X-linked hypophosphatemia
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Burosumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Trevogrumab
Chemical compound
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Caplacizumab
Chemical compound
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Bococizumab
Antibody tested against Alzheimer's
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Crenezumab
Monoclonal antibody medication
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Solanezumab
Bevirimat SM 2012 Ivacaftor 2012 2032 SM 2013 Vilanterol 2013 2033 SM 2014 Evolocumab 2015 2035 MA 2014 Umeclidinium bromide (Incruese Ellipta) 2014 2034 SM
List of drugs by year of discovery
List_of_drugs_by_year_of_discovery
Chemical compound
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Bapineuzumab
Pharmaceutical compound
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Indium_(111In)_imciromab
Monoclonal antibody protein
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Gantenerumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Enoticumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Volociximab
Medication
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Bentracimab
Pharmaceutical drug
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Ranibizumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Eptinezumab
Anti-tau monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Semorinemab
Scientific study of lipids
achieved through the use of monoclonal antibodies targeting PCSK9, such as evolocumab and alirocumab. This approach offers a potential solution for individuals
Lipidology
Pharmaceutical compound
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Amlenetug
of 2017, no drug exists that is able to do this. 17 March A new drug, evolocumab, is shown to prevent heart attacks and strokes by dramatically cutting
2017_in_science
Form of immunotherapy
human CGRP receptor Migraine headache prevention 761077 Link[dead link] evolocumab Repatha Amgen 8/27/2015 subcutaneous fully human PCSK9 Heterozygous familial
Monoclonal_antibody_therapy
Chemical compound
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Blosozumab
Pharmaceutical drug
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Ramucirumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Abelacimab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Opicinumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Refanezumab
Medication for macular degeneration
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Faricimab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Fasinumab
Pharmaceutical drug
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Brolucizumab
Pharmaceutical compound
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Indium_(111In)_biciromab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Inclacumab
Chemical compound
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Tanezumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Vanucizumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Ponezumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Etaracizumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Evinacumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Demcizumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Stamulumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Orticumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Ozanezumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Ralpancizumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Nesvacumab
Pharmaceutical compound
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Devextinetug
Chemical compound
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Fulranumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Icrucumab
Monoclonal antibody
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Tadocizumab
Chemical compound
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Ascrinvacumab
Pharmaceutical drug
Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab Rinucumab
Alacizumab_pegol
EVOLOCUMAB
EVOLOCUMAB
EVOLOCUMAB
EVOLOCUMAB
EVOLOCUMAB
EVOLOCUMAB
EVOLOCUMAB
EVOLOCUMAB
EVOLOCUMAB